BackBiohaven Overview
Biohaven Ltd

Biohaven Target Price

Analysts' average 12-month price target for Biohaven is $20.

Get informed when a big investor buys or sells

+ Follow

Share Price

$13.62

Average Target Price

$20.0046.8% upside

5 analysts in the last 4 months

High: $30 | Low: $11

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-08RBC CapitalLeonid Timashev$1939.5% upsideOpen
2026-08-28Canaccord GenuitySumant Kulkarni$2154.2% upsideOpen
2026-08-26Raymond JamesChris Raymond$30120.3% upsideOpen
2026-08-12Morgan Stanley$1939.5% upsideOpen
2026-06-29Needham$1119.2% downsideOpen
2026-05-13Morgan StanleyTerence Flynn$1832.2% upsideOpen
2026-03-04H.C. WainwrightDouglas Tsao$1026.6% downsideOpen
2026-03-03Leerink PartnersMarc Goodman$1510.1% upsideOpen
2026-02-05Goldman Sachs$2368.9% upsideOpen
2026-01-21RBC Capital$2261.5% upsideOpen
2025-12-03H.C. Wainwright$1119.2% downsideOpen
2025-11-26UBS$1119.2% downsideOpen
2025-11-18Morgan Stanley$2690.9% upsideOpen
2025-11-05Robert W. BairdBrian Skorney$42208.4% upsideOpen
2025-03-20Deutsche Bank$60340.5% upsideOpen
2025-03-04Bernstein$57318.5% upsideOpen
2024-12-04RBC CapitalLeonid Timashev$61347.9% upsideOpen
2024-10-15Bank of America SecuritiesJason Gerberry$65377.2% upsideOpen
2024-09-24Leerink PartnersMarc Goodman$60340.5% upsideOpen
2024-09-24H.C. WainwrightDouglas Tsao$59333.2% upsideOpen
2024-09-24Bank of America SecuritiesJason Gerberry$62355.2% upsideOpen
2024-09-24RBC CapitalLeonid Timashev$68399.3% upsideOpen
2024-09-23Robert W. BairdBrian Skorney$60340.5% upsideOpen
2024-09-23BTIGThomas Shrader$59333.2% upsideOpen
2024-09-16JefferiesAmy Li$57318.5% upsideOpen
2024-09-04Tudor PickeringWilliam Pickering$55303.8% upsideOpen
2024-07-24Morgan StanleyTerence Flynn$58325.8% upsideOpen
2024-05-29Robert W. BairdBrian Skorney$58325.8% upsideOpen
2024-05-29RBC CapitalLeonid Timashev$59333.2% upsideOpen
2023-01-04J.P. Morgan$2368.9% upsideOpen
2022-12-02BTIG$2476.2% upsideOpen

Biohaven (BHVN) FAQ

As of the most recent data, BHVN shows a target price of $20. Scroll down for historical charts and peer comparison views.

If Biohaven moved to the average analyst target of $20, shares would be roughly 46.8% higher than $13.62. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Biohaven's earnings trajectory.

Besides this target price page, Stockcircle has Biohaven's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $20) with ownership activity and broader fundamentals.

Biohaven's target price is $20; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.